1. Home
  2. XOMA vs MTLS Comparison

XOMA vs MTLS Comparison

Compare XOMA & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • MTLS
  • Stock Information
  • Founded
  • XOMA N/A
  • MTLS 1990
  • Country
  • XOMA United States
  • MTLS Belgium
  • Employees
  • XOMA N/A
  • MTLS N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • MTLS Computer Software: Prepackaged Software
  • Sector
  • XOMA Health Care
  • MTLS Technology
  • Exchange
  • XOMA Nasdaq
  • MTLS Nasdaq
  • Market Cap
  • XOMA 298.3M
  • MTLS 302.4M
  • IPO Year
  • XOMA N/A
  • MTLS 2014
  • Fundamental
  • Price
  • XOMA $27.41
  • MTLS $5.98
  • Analyst Decision
  • XOMA Strong Buy
  • MTLS Buy
  • Analyst Count
  • XOMA 2
  • MTLS 1
  • Target Price
  • XOMA $57.00
  • MTLS $9.50
  • AVG Volume (30 Days)
  • XOMA 34.9K
  • MTLS 72.1K
  • Earning Date
  • XOMA 08-06-2024
  • MTLS 07-24-2024
  • Dividend Yield
  • XOMA N/A
  • MTLS N/A
  • EPS Growth
  • XOMA N/A
  • MTLS 500.00
  • EPS
  • XOMA N/A
  • MTLS 0.13
  • Revenue
  • XOMA $5,811,000.00
  • MTLS $291,541,304.00
  • Revenue This Year
  • XOMA $349.94
  • MTLS $6.21
  • Revenue Next Year
  • XOMA $28.50
  • MTLS $9.47
  • P/E Ratio
  • XOMA N/A
  • MTLS $45.50
  • Revenue Growth
  • XOMA 73.10
  • MTLS 9.50
  • 52 Week Low
  • XOMA $13.48
  • MTLS $4.70
  • 52 Week High
  • XOMA $29.00
  • MTLS $9.10
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 57.75
  • MTLS 76.63
  • Support Level
  • XOMA $25.46
  • MTLS $4.76
  • Resistance Level
  • XOMA $29.00
  • MTLS $5.06
  • Average True Range (ATR)
  • XOMA 1.39
  • MTLS 0.18
  • MACD
  • XOMA 0.35
  • MTLS 0.11
  • Stochastic Oscillator
  • XOMA 75.35
  • MTLS 98.45

About XOMA XOMA Corporation

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About MTLS Materialise NV

Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, Poland, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.

Share on Social Networks: